Medtronic Gross Margin 2012-2026 | MDT
Current and historical gross margin for Medtronic (MDT) over the last 10 years. The current gross profit margin for Medtronic as of July 31, 2026 is %.
| Medtronic Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-07-31 | $37.54B | $24.41B | 65.01% |
| 2026-04-30 | $36.36B | $23.64B | 65.02% |
| 2026-01-31 | $35.48B | $23.01B | 64.86% |
| 2025-10-31 | $34.76B | $22.77B | 65.51% |
| 2025-07-31 | $34.20B | $22.33B | 65.29% |
| 2025-04-30 | $33.54B | $21.91B | 65.32% |
| 2025-01-31 | $33.20B | $21.67B | 65.27% |
| 2024-10-31 | $33.00B | $21.46B | 65.04% |
| 2024-07-31 | $32.58B | $21.23B | 65.16% |
| 2024-04-30 | $32.36B | $21.15B | 65.34% |
| 2024-01-31 | $32.32B | $21.17B | 65.50% |
| 2023-10-31 | $31.96B | $20.90B | 65.40% |
| 2023-07-31 | $31.56B | $20.73B | 65.68% |
| 2023-04-30 | $31.23B | $20.51B | 65.67% |
| 2023-01-31 | $30.77B | $20.44B | 66.43% |
| 2022-10-31 | $30.81B | $20.71B | 67.21% |
| 2022-07-31 | $31.07B | $21.01B | 67.61% |
| 2022-04-30 | $31.69B | $21.54B | 67.98% |
| 2022-01-31 | $31.79B | $21.58B | 67.89% |
| 2021-10-31 | $31.80B | $21.43B | 67.39% |
| 2021-07-31 | $31.60B | $21.02B | 66.53% |
| 2021-04-30 | $30.12B | $19.63B | 65.19% |
| 2021-01-31 | $27.93B | $17.83B | 63.85% |
| 2020-10-31 | $27.87B | $17.99B | 64.57% |
| 2020-07-31 | $27.93B | $18.36B | 65.76% |
| 2020-04-30 | $28.91B | $19.49B | 67.41% |
| 2020-01-31 | $31.06B | $21.42B | 68.96% |
| 2019-10-31 | $30.89B | $21.38B | 69.22% |
| 2019-07-31 | $30.67B | $21.35B | 69.62% |
| 2019-04-30 | $30.56B | $21.40B | 70.04% |
| 2019-01-31 | $30.56B | $21.49B | 70.32% |
| 2018-10-31 | $30.38B | $21.38B | 70.38% |
| 2018-07-31 | $29.95B | $21.03B | 70.22% |
| 2018-04-30 | $29.95B | $20.89B | 69.73% |
| 2018-01-31 | $29.73B | $20.62B | 69.36% |
| 2017-10-31 | $29.64B | $20.46B | 69.02% |
| 2017-07-31 | $29.93B | $20.55B | 68.65% |
| 2017-04-30 | $29.71B | $20.42B | 68.72% |
| 2017-01-31 | $29.36B | $20.14B | 68.60% |
| 2016-10-31 | $29.01B | $19.92B | 68.66% |
| 2016-07-31 | $28.73B | $19.78B | 68.85% |
| 2016-04-30 | $28.83B | $19.69B | 68.29% |
| 2016-01-31 | $28.57B | $18.86B | 66.00% |
| 2015-10-31 | $25.95B | $17.25B | 66.48% |
| 2015-07-31 | $23.26B | $15.60B | 67.07% |
| 2015-04-30 | $20.26B | $13.95B | 68.86% |
| 2015-01-31 | $17.52B | $12.98B | 74.06% |
| 2014-10-31 | $17.37B | $12.90B | 74.27% |
| 2014-07-31 | $17.20B | $12.78B | 74.32% |
| 2014-04-30 | $17.01B | $12.67B | 74.52% |
| 2014-01-31 | $16.90B | $12.60B | 74.58% |
| 2013-10-31 | $16.76B | $12.52B | 74.68% |
| 2013-07-31 | $16.67B | $12.49B | 74.95% |
| 2013-04-30 | $16.59B | $12.46B | 75.13% |
| 2013-01-31 | $16.43B | $12.39B | 75.41% |
| 2012-10-31 | $16.32B | $12.35B | 75.66% |
| 2012-07-31 | $16.25B | $12.34B | 75.93% |
| 2012-04-30 | $16.18B | $12.30B | 75.97% |
| 2012-01-31 | $15.86B | $12.11B | 76.33% |
| 2011-10-31 | $15.80B | $12.04B | 76.22% |
| 2011-07-31 | $15.68B | $11.92B | 76.03% |
| 2011-04-30 | $15.51B | $11.81B | 76.14% |
| 2011-01-31 | $15.30B | $11.73B | 76.67% |
| 2010-10-31 | $15.30B | $11.75B | 76.81% |
| 2010-07-31 | $15.23B | $11.72B | 76.96% |
| 2010-04-30 | $15.39B | $11.81B | 76.73% |
| 2010-01-31 | $15.45B | $11.72B | 75.85% |
| 2009-10-31 | $15.09B | $11.43B | 75.70% |
| 2009-07-31 | $14.83B | $11.20B | 75.52% |
| 2009-04-30 | $14.60B | $11.08B | 75.90% |
| 2009-01-31 | $14.63B | $11.10B | 75.87% |
| 2008-10-31 | $14.54B | $10.99B | 75.57% |
| 2008-07-31 | $14.09B | $10.59B | 75.10% |
| 2008-04-30 | $13.52B | $10.07B | 74.50% |
| 2008-01-31 | $12.94B | $9.57B | 73.96% |
| 2007-10-31 | $12.58B | $9.31B | 73.98% |
| 2007-07-31 | $12.53B | $9.30B | 74.24% |
| 2007-04-30 | $12.30B | $9.13B | 74.24% |
| 2007-01-31 | $12.09B | $9.02B | 74.61% |
| 2006-10-31 | $11.81B | $8.82B | 74.65% |
| 2006-07-31 | $11.50B | $8.61B | 74.84% |
| 2006-04-30 | $11.29B | $8.48B | 75.07% |
| 2006-01-31 | $11.00B | $8.25B | 74.98% |
| 2005-10-31 | $10.76B | $8.10B | 75.29% |
| 2005-07-31 | $10.40B | $7.85B | 75.48% |
| 2005-04-30 | $10.06B | $7.61B | 75.67% |
| 2005-01-31 | $9.94B | $7.54B | 75.81% |
| 2004-10-31 | $9.61B | $7.27B | 75.66% |
| 2004-07-31 | $9.37B | $7.08B | 75.57% |
| 2004-04-30 | $9.09B | $6.83B | 75.21% |
| 2004-01-31 | $8.57B | $6.44B | 75.15% |
| 2003-10-31 | $8.29B | $6.22B | 75.08% |
| 2003-07-31 | $8.02B | $6.03B | 75.16% |
| 2003-04-30 | $7.67B | $5.78B | 75.33% |
| 2003-01-31 | $7.31B | $5.50B | 75.28% |
| 2002-10-31 | $6.99B | $5.25B | 75.05% |
| 2002-07-31 | $6.67B | $4.98B | 74.69% |
| 2002-04-30 | $6.41B | $4.76B | 74.23% |
| 2002-01-31 | $6.14B | $4.55B | 74.06% |
| 2001-10-31 | $5.91B | $4.38B | 74.17% |
| 2001-07-31 | $5.70B | $4.23B | 74.17% |
| 2001-04-30 | $5.55B | $4.14B | 74.60% |
| 2001-01-31 | $5.47B | $4.05B | 74.08% |
| 2000-10-31 | $5.36B | $3.97B | 73.99% |
| 2000-07-31 | $5.16B | $3.82B | 73.92% |
| 2000-04-30 | $4.96B | $3.65B | 73.67% |
| 2000-01-31 | $4.67B | $3.34B | 71.47% |
| 1999-10-31 | $4.48B | $3.17B | 70.88% |
| 1999-07-31 | $4.30B | $3.09B | 71.90% |
| 1999-04-30 | $4.19B | $3.09B | 73.65% |
| 1999-01-31 | $3.73B | $2.88B | 77.14% |
| 1998-10-31 | $3.29B | $2.57B | 77.92% |
| 1998-07-31 | $2.95B | $2.27B | 76.98% |
| 1998-04-30 | $2.60B | $1.94B | 74.31% |
| 1998-01-31 | $2.56B | $1.92B | 74.99% |
| 1997-10-31 | $2.53B | $1.90B | 75.35% |
| 1997-07-31 | $2.48B | $1.87B | 75.23% |
| 1997-04-30 | $2.44B | $1.83B | 74.94% |
| 1997-01-31 | $2.40B | $1.78B | 74.49% |
| 1996-10-31 | $2.33B | $1.73B | 74.16% |
| 1996-07-31 | $2.25B | $1.65B | 73.53% |
| 1996-04-30 | $2.17B | $1.58B | 72.88% |
| 1996-01-31 | $2.09B | $1.50B | 71.56% |
| 1995-10-31 | $1.98B | $1.40B | 70.60% |
| 1995-07-31 | $1.86B | $1.30B | 69.74% |
| 1995-04-30 | $1.74B | $1.20B | 68.96% |
| 1995-01-31 | $1.62B | $1.11B | 68.68% |
| 1994-10-31 | $1.54B | $1.06B | 68.70% |
| 1994-07-31 | $1.46B | $1.01B | 68.65% |
| 1994-04-30 | $1.39B | $0.96B | 68.87% |
| 1994-01-31 | $1.36B | $0.93B | 68.81% |
| 1993-10-31 | $1.33B | $0.91B | 68.70% |
| 1993-07-31 | $1.33B | $0.91B | 68.70% |
| 1993-04-30 | $1.33B | $0.91B | 68.37% |
| 1993-01-31 | $1.30B | $0.89B | 68.40% |
| 1992-10-31 | $1.30B | $0.88B | 67.88% |
| 1992-07-31 | $1.24B | $0.84B | 67.47% |
| 1992-04-30 | $1.18B | $0.80B | 67.54% |
| 1992-01-31 | $1.13B | $0.77B | 67.61% |
| 1991-10-31 | $1.09B | $0.74B | 68.05% |
| 1991-07-31 | $1.06B | $0.72B | 67.89% |
| 1991-04-30 | $1.02B | $0.69B | 67.51% |
| 1991-01-31 | $1.00B | $0.67B | 67.13% |
| 1990-10-31 | $0.95B | $0.64B | 66.95% |
| 1990-07-31 | $0.90B | $0.61B | 67.41% |
| 1990-04-30 | $0.87B | $0.58B | 67.44% |
| 1990-01-31 | $0.82B | $0.55B | 67.15% |
| 1989-10-31 | $0.80B | $0.54B | 67.21% |
| 1989-07-31 | $0.78B | $0.53B | 67.39% |
| 1989-04-30 | $0.77B | $0.52B | 67.49% |
| 1989-01-31 | $0.73B | $0.50B | 67.67% |
| 1988-10-31 | $0.71B | $0.48B | 67.88% |
| 1988-07-31 | $0.68B | $0.46B | 67.69% |
| 1988-04-30 | $0.65B | $0.44B | 67.84% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $119.983B | $36.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |